by PRI | Jun 20, 2022 | Microbiome Pre-Clinical Research (CRO)
Massimo Marzorati CEO The most complete in vitro technology platform (from high-throughput to detailed MoA) to assess the fate of Microbiome-based medicinal products along the GI tract....
by PRI | Jun 17, 2022 | Microbiome Pre-Clinical Research (CRO)
Andrew Pridmore Head of Science GLP compliant contract microbiological laboratory services, specializing in antibiotic susceptibility testing and cultivation of highly fastidious bacterial strains....
by PRI | Jun 17, 2022 | Microbiome Pre-Clinical Research (CRO)
Bruno Bariohay CEO BIOMEOSTASIS provides preclinical in vivo pharmacology services in the field of metabolic, GI and aged-related disorders....
